Cramer: Sell BankUnited and Buy Acorda, Charles River Labs and These 2 Sizzling Stocks

Jim Cramer made the following calls on January 9th, 2013. What do you think about his picks?

Acorda Therapeutics, Inc. (NASDAQ:ACOR): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on June 19, 2012. The stock’s 52-week high is $28.46, and its 52-week low is $21.04.

Current Price $27.34

ACOR